Global InformationTherapure BioPharma Inc information
 | |
| Company type | Biotechnology |
|---|---|
| Industry | Biopharmaceutical, Biomanufacturing, biotechnology |
| Founded | 2008 |
| Headquarters | Mississauga, Ontario, Canada |
Key people | Nicholas Green (CEO), Rajan Puri (Director) |
| Products | Therapeutic Proteins[1][2] |
Number of employees | 300 |
| Website | http://www.therapurebio.com |
Therapure BioPharma, Inc. is a Canadian biopharmaceutical industry and biotechnology company, headquartered in Mississauga, Ontario, a privately held, integrated Contract Development and Manufacturing Organization (CDMO). Founded in 2008, the firm provides a range of therapeutic protein development and manufacturing services including; technology transfer & process development, analytical development and testing, scale up and cGMP manufacturing, and aseptic fill/finish and lyophilization. As of 2010[update], the company has over 90 employees.[3] In 2020, Therapure was acquired by Resilience.[4]
- ^ "Outsourcing Pharma". Gareth Macdonald.
- ^ "Canadian Business Journal". Canadian Business Journal.
- ^ "Bio Science World". Shawn Lawrence.
- ^ Mullins, Rick (November 25, 2020). "Pharmaceutical services firm Resilience debuts, with questions". cen.acs.org. Retrieved 25 May 2023.